Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Amid Growing Interest in Cryptocurrencies, LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Roots Growth in Lightning Network Success in 2021

Arizona and Wyoming have introduced proposals for their states to introduce tax payments by digital currency India is working toward incorporating a digital rupee, including the implementation of a 30% tax on income earned from digital currency investments to begin during 2022 LQwD’s growth is centered on the success of the Lightning Network and the […]

Focused on Pillars of Success for 2022, Friendable Inc. (FDBL) Disrupts Traditional Music Industry with “Anti-Label” Opportunities

Friendable recorded a 14,000% YOY increase in revenue (more than $20,000 in January 2022) and more than 8,000% YOY growth of its Fan Pass Live artist database, topping 105,000 artists Fan Pass Live platform offers the only all-inclusive option for independent artists, from live performances and merchandise creation (and sales) to music recording and distribution […]

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that […]

Identified Psilocybin and MDMA Supplier, New Addition Strengthens Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Board Experience

Biotechnology company Mydecine Innovations Group is devoted to advancing the use of psychedelics for the treatment of mental illnesses and addiction Mydecine has necessary license to provide psilocybin and MDMA under Canada’s SAP program, which allows medical providers to request otherwise unavailable drug substances for the treatment of patients who have not seen success with […]

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Pushing the Conversation on Psychedelics and Access to Psychedelic Treatments for Persons Living with Mental Health Conditions

Delic seeks to bring mental health treatment closer to the people through an aggressive expansion plan In a study conducted by The Harris Poll on behalf of the company, it was noted that 65% of Americans dealing with mental health conditions believe that psychedelic medicine should be made available Studies such as these are helping […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Releases International Nodes; Bitcoin Payment Ecosystem Market Expected to Reach US$880 Million by 2026

LQwD currently has three public nodes on the Lightning Network – US-West, Singapore, and Frankfurt LQwD’s first launched node, US-West has already experienced positive growth The company plans to release more international nodes in the future, facilitating its goal of being a prominent payment processor worldwide LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech company […]

Microdose Psychedelics Molecular Masterclass: LSD Conference Set to Explore The Potential Of LSD

Biotech experts, top LSD researchers, science specialists, influencers, and medical professionals are invited to attend the virtual LSD Conference being held on February 17, 2022. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers focused on the research regarding therapeutic benefits and potential of LSD. The conference is organized by […]

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third year Perhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 […]

Nemaura Medical Inc.’s (NASDAQ: NMRD) CEO Dr. Faz Chowdhury Addresses Growing CGM Demand at H.C. Wainwright BioConnect Conference

NMRD CEO Dr. Faz Chowdhury presented at H.C. Wainwright BioConnect Conference held January 10-13, 2022 Presentation revealed growing need for CGM devices, diabetes market estimated at $150 billion NMRD’s sugarBEAT(R) devices measure glucose at the skin surface, non-invasive, easy to use NMRD recently commenced product shipments in lieu of an order for 5,000 CGM devices […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.